CA

Canada

CA

North America

Regulatory Overview

Canada is regulated by the Health Canada. The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

Health Canada

Regulatory Pathways (1)

Health Canada's SAP allows manufacturers to sell drugs not approved in Canada to practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable.

Application Form: HC/SC 3011 SAP Request Form
Legal Basis: Section C.08.010 Food and Drug Regulations
Eligibility: Serious or life-threatening condition with no locally registered alternative
Reference: Health Canada SAP Guidance

Drugs Available (196)

DrugAccess RouteStatusLead Time
alglucosidase alfa
cytarabine
eliglustat
vitamin A (retinol)
furosemide
eribulin mesylate
Digoxin Immune Fab
Sucralfate
Dorzolamide
Pravastatin
Temsirolimus
naproxen
Memantine
propranolol
tamoxifen citrate
atropine sulfate
metoprolol
carbamazepine
ruxolitinib
Melphalan
mycophenolate mofetil
Epoprostenol
Sodium Phenylbutyrate
etanercept
Denosumab
dapsone
Tofacitinib
mavacamten
minoxidil
ibuprofen
gabapentin
Hydroxychloroquine
cyclophosphamide
Anakinra
bosentan
bimatoprost
testosterone
Artificial tears
Rho(D) immune globulin
Baclofen
Dexrazoxane
Vigabatrin
Clobazam
phacoemulsification surgery
melatonin
amiodarone
Total Parenteral Nutrition
Growth hormone (somatropin)
ascorbic acid
hormone replacement therapy (estrogen/progesterone)
Busulfan
Digoxin
Romidepsin
Interferon gamma-1b
collagenase clostridium histolyticum
physical therapy and orthotic management
Retinoids (Tretinoin)
eculizumab
miglustat
Betaine anhydrous
tizanidine
Octreotide
aspirin
oxybutynin
Valproic Acid
tocilizumab
sclerostin antibody
Immunoglobulin
Mesalamine
alpha-L-iduronidase
Intravenous Immunoglobulin (IVIG)
Phenytoin
Bisphosphonates (pamidronate)
Metronidazole
Nitisinone
Human Chorionic Gonadotropin (hCG)
treprostinil
sirolimus
temozolomide
Carnitine
brivaracetam
Infliximab
folic acid
Pyridoxine
Acetazolamide
Clomiphene Citrate
Angiotensin-Converting Enzyme Inhibitors (Enalapril)
Multivitamin with Calcium and Vitamin D
levothyroxine sodium
botulinum toxin type A
Levothyroxine
mexiletine
azathioprine
sunscreen (broad spectrum SPF 50+)
galantamine
ambrisentan
Brentuximab vedotin
L-carnitine
insulin
luspatercept
trabectedin
eplontersen
prednisolone
Tegaserod
rituximab
Dapagliflozin
allopurinol
Carboplatin
Topical corticosteroids
estradiol
Erythromycin
Doxycycline
calcium carbonate
coenzyme Q10
Patisiran
Tolvaptan
cerliponase alfa
belumosudil
adalimumab
Imiglucerase
Amphotericin B liposomal
ranibizumab
metformin
Methotrexate
carglumic acid
Alendronate Sodium
calcitriol
doxorubicin
Pyridostigmine
Levetiracetam
Acitretin
prednisone
salicylic acid
Insulin glargine
cochlear implant
Pyridostigmine Bromide
aflibercept
laronidase
Romiplostim
Bleomycin
hydroxycobalamin
Laser photocoagulation therapy
acetaminophen
pregabalin
riboflavin
N-acetylcysteine
Occupational and Physical Therapy Support
eptinezumab
Pamidronate
nitroglycerin
Sacrosidase
ezetimibe
Belzutifan
atorvastatin
bevacizumab
proton pump inhibitors (omeprazole)
mecasermin
celecoxib
Biotin
Imiquimod
cyclosporine ophthalmic
Growth Hormone
deferasirox
Diatrizoate
Tafamidis
urea
Levodopa/Carbidopa
Lanreotide
cyanocobalamin
Sodium Bicarbonate
diazoxide
baricitinib
Zoledronic Acid
Hypertonic saline
Clonazepam
Zidovudine
emollients with keratolytics
warfarin
Vitamin K1 (Phytonadione)
cornstarch
disopyramide
Sunitinib
Cisplatin
imatinib mesylate
nimodipine
Colchicine
surgical repair
Tamoxifen
Artificial tears (Hypromellose)
vitamin D3
Sildenafil
sotalol
Hematopoietic stem cell transplantation
Diazepam
Timolol maleate
Amnioreduction
CA
Canada
ISO CodeCA
RegionNorth America
Regulatory AuthorityHealth Canada
Pathways1 documented
Drugs Available196 drug(s)